Karla works with eligible patients exploring wellness-focused peptide programs, including Tesamorelin, Ipamorelin, CJC-1295, GHK-Cu, GLOW Mix, KLOW, Wolverine Blend, NAD+ therapy, and physician-guided medical weight loss programs
However, the risk for thyroid cancer was significantly higher within the first year after GLP-1RA initiation and was amplified in the overall as-treated analysis that censored patients when therapy was discontinued or another medication was added. The research team indicates this could be a sign that GLP-1 users are being screened for thyroid cancer at a higher rate than other diabetes drugs, resulting in a spike in diagnoses in the first year of taking the drug
A pilot 3-month sitagliptin treatment increases serum adiponectin level in Japanese patients with type 2 diabetes mellitusa randomized controlled trial START-J study
Personalized Dosing and the PlexusDx Precision Approach The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R variants that relate to GLP-1 and related signaling pathways
It helps fade these marks significantly faster than letting them heal naturally